Myotonic Dystrophy

Type: Keyphrase
Name: Myotonic Dystrophy
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Three U.Va. Researchers Win Hartwell Awards to Improve Children's Health

Contact InformationAvailable for logged-in reporters onlyNewswise — neurologist Dr. Erin Pennock Foff, biologist Sarah Kucenas and biomedical engineer Shayn Peirce-Cotter have been named recipients of 2013 Hartwell Individual Biomedical Research Awards ... [Published Newswise - 20 hours ago]
First reported Apr 17 2014 - Updated Apr 18 2014 - 2 reports

How Basic Research Fuels Medical Advances | NIGMS

This image may look complicated, but it tells a fairly straightforward tale about basic research: Learning more about basic life processes can pave the way for medical and other advances. In this example, researchers led by Matthew Disney of the Scripps ... [Published DailyMe.Com - Apr 18 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Lincoln fundraisers run the London Marathon

Runners from Lincoln are resting their feet after completing the 2014 Virgin London Marathon on Sunday, April 13.Some 36,000 people took part in the 26.2 mile road race and, among them, Lincoln fundraisers completed the course for charity.Lincoln’s Winter ... [Published The Lincolnite - Apr 14 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Prosensa to Appoint Michael Wyzga to Supervisory Board

(GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, today announced that Michael S. Wyzga has been nominated for appointment to its Supervisory Board at ... [Published Benzinga.com - Apr 08 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Brain Connectivity, Personality Traits in Myotonic Dystrophy

Reuters Health InformationBy Reuters StaffApril 07, 2014NEW YORK (Reuters Health) - Functional brain abnormalities may explain atypical personality traits in adults with myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, hints ... [Published American Journal of Public Health - Apr 07 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Rosetta and Marina collaborate to develop microRNA-based diagnostic products

Rosetta Genomics Ltd., a provider of microRNA-based molecular diagnostics and therapeutics, and Marina Biotech, Inc., a nucleic acid-based drug discovery and development company, have announced a strategic alliance to identify and develop microRNA-based ... [Published Individual.com - Apr 07 2014]
First reported Apr 05 2014 - Updated Apr 05 2014 - 2 reports

Rosetta Genomics, Marina Biotech ink alliance for rare diseases

Rosetta Genomics , a developer and provider of microRNA-based molecular diagnostics and therapeutics, and Marina Biotech , a nucleic acid-based drug discovery and development company focused on rare diseases, have established a strategic alliance to identify ... [Published Center Watch - Apr 05 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Healthcare Review: Alnylam, Ariad Pharmaceuticals, Myriad Genetics, Rosetta Genomics, MannKind Corporation

U.S. stocks made modest gains on Wednesday and the S&P 500 held near its record high of the prior session after data suggested the economy is recovering from a winter-driven slowdown.U.S. private employers added 191,000 workers in March, slightly below ... [Published BioMedReports - Apr 02 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Rosetta Genomics and Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics and Therapeutics for Rare Diseases

SOURCE: Marina Biotech, Inc.Alliance Combines Industry Leading microRNA Biomarker and Target Discovery Platform With Proprietary microRNA Drug Discovery EnginePRINCETON, NJ and REHOVOT, ISRAEL and BOSTON, MA--(Marketwired - Apr 2, 2014) - Rosetta Genomics ... [Published MarketWired - Apr 02 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Dundee and St Andrews researchers shedding new light on diseases

Researchers at Dundee and St Andrews universities have produced new insights into two muscle-wasting diseases, including ‘floppy baby syndrome’, the leading genetic cause of death in children.Their findings have cast further light on how the genetic defect ... [Published Evening Telegraph - Apr 02 2014]
First reported Mar 17 2014 - Updated Mar 18 2014 - 2 reports

Prosensa Announces Full Year 2013 Financial Results and Recent Corporate Developments

(GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today reported financial results for the full year ending December 31, 2013, and ... [Published GlobeNewswire - Mar 18 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 1 reports

Biogen Idec Inc (BIIB): Pipeline Offers Several Transformational Opportunities

Biogen Idec Inc (NASDAQ:BIIB) has been outperforming for several years from the strength of its multiple sclerosis (MS) treatments -- Tecfidera and Tysabri. Now, the focus is starting to move to BIIB's burgeoning pipeline to sustain, and potentially accelerate ... [Published I Stock Analyst - Mar 14 2014]

Quotes

"TABLE-US-00008 Component Amount (% by weight) Compound 1 0.50 PEG 400 49.50 Vitamin E TPGS 11.20 Water 38.80"

More Content

All (30) | News (28) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Highly Specific Contractions of a Single CAG/CT... [Published PLoS medicine - 10 hours ago]
Three U.Va. Researchers Win Hartwell Awards to ... [Published Newswise - 20 hours ago]
How Basic Research Fuels Medical Advances | NIGMS [Published DailyMe.Com - Apr 18 2014]
How Basic Research Fuels Medical Advances [Published LiveScience.com - Apr 17 2014]
VERTEX PHARMACEUTICALS : "Formulations of ®-1-(... [Published 4 Traders - Apr 16 2014]
Lincoln fundraisers run the London Marathon [Published The Lincolnite - Apr 14 2014]
Prosensa to Appoint Michael Wyzga to Supervisor... [Published Benzinga.com - Apr 08 2014]
Brain Connectivity, Personality Traits in Myoto... [Published American Journal of Public Health - Apr 07 2014]
Rosetta and Marina collaborate to develop micro... [Published Individual.com - Apr 07 2014]
Rosetta Genomics, Marina Biotech ink alliance f... [Published Center Watch - Apr 05 2014]
Rosetta, Marina Biotech collaborate to identify... [Published PharmaBiz - Apr 05 2014]
Healthcare Review: Alnylam, Ariad Pharmaceutica... [Published BioMedReports - Apr 02 2014]
Rosetta Genomics and Marina Biotech Establish S... [Published MarketWired - Apr 02 2014]
Dundee and St Andrews researchers shedding new ... [Published Evening Telegraph - Apr 02 2014]
Isis Pharmaceuticals Reports Interim Results fr... [Published CWEB News - Mar 20 2014]
Camborne girl has faced surgeon’s knife 12 time... [Published Truro People - Mar 18 2014]
Prosensa Announces Full Year 2013 Financial Res... [Published GlobeNewswire - Mar 18 2014]
Prosensa Announces 48-Week Data from a U.S. Pha... [Published Benzinga.com - Mar 17 2014]
Family fights challenges of muscular dystrophy [Published Leaf Chronicle - Mar 17 2014]
Biogen Idec Inc (BIIB): Pipeline Offers Several... [Published I Stock Analyst - Mar 14 2014]
Scientists uncover trigger for most common form... [Published 4 Traders - Mar 12 2014]
Marina Biotech to Use Its RNAi, Antisense and m... [Published 4 Traders - Mar 11 2014]
The Top 10 Penny Stocks of 2014 [Published Money Morning - Mar 10 2014]
Myotonic Dystrophy Foundation Recognizes Rare D... [Published PR Newswire: Policy & Public Interest - Feb 19 2014]
Isis Pharma advances phase II study evaluating ... [Published PharmaBiz - Feb 15 2014]
Production of viral vectors [Published PharmCast - Feb 14 2014]
Prosensa to Participate at Upcoming Investor Co... [Published Stockwatch - Jan 31 2014]
Methods and compositions for treatment of myoto... [Published PharmCast - Jan 01 2014]
Prosensa Comments on Drisapersen Program Update [Published GlobeNewswire - Dec 19 2013]
Isis receives milestone payment from Biogen Ide... [Published Pharmaceutical Technology - Oct 17 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Myotonic Dystrophy Foundation Recognizes Rare D... [Published PR Newswire: Policy & Public Interest - Feb 19 2014]
SAN FRANCISCO, Feb. 19, 2014 /PRNewswire-USNewswire/ -- In recognition of Rare Disease Month and Rare Disease Day The Myotonic Dystrophy Foundation (MDF) has released "Hope and Inspiration"—a short eight minute video that brings attention to myotonic ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.